Grapheal
Founded 2019 · 9 employees on LinkedIn · 1 known investors
Grapheal develops graphene-based biosensors, including PFAST, a field-deployable device for fast, real-time detection of ultra-trace PFAS ("forever chemicals") in water. The platform enables point-of-need testing to support PFAS monitoring under regulations such as the EU Drinking Water Directive.
Investors · 1
Frequently asked questions
- What does Grapheal do?
- Grapheal develops graphene-based biosensors, including PFAST, a field-deployable device for fast, real-time detection of ultra-trace PFAS ("forever chemicals") in water. The platform enables point-of-need testing to support PFAS monitoring under regulations such as the EU Drinking Water Directive.
- Who are Grapheal's investors?
- Grapheal's investors include Novalis Biotech.